What they were paid
Coherus Oncology Director Compensation Table · all 4 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | — | $61,667 | — | $121,667 |
| FY2023 | $57,500 | — | $128,692 | — | $186,192 |
| FY2022 | $57,500 | — | $385,101 | — | $442,601 |
| FY2021 | — | — | — | — | — |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coherus Oncology, Inc. DEF 14A filed April 20, 2026, accession 0001104659-26-045251, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Coherus Oncology, Inc. filed document, accession 0001104659-26-045251. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.
Get the Coherus Oncology Board Governance Report
$121,667 Lee N. Newcomer, MD, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 20, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Coherus Oncology pays directors a $50,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Coherus Oncology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Ali J. Satvat | Independent Director | $144,167 |
| Charles W. Newton | Independent Director | $144,167 |
| Dennis M. Lanfear | Chair of the Board | — |
| Georgia Erbez | Independent Director | $134,167 |
| Jill O'Donnell-Tormey, Ph.D | Independent Director | $116,667 |
| Mats L. Wahlström | Lead Independent Director | $191,667 |
| Michael Ryan | Independent Director | $131,042 |
| Rita A. Karachun | Independent Director | $139,167 |
The full Coherus Oncology compensation record
free company briefThis page is one director within Coherus Oncology's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Coherus Oncology proxy · each links to its own free briefOrder CHRS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.